AU Patent

AU2010238854A1 — Paracetamol for parenteral administration

Assigned to Fresenius Kabi Deutschland GmbH · Expires 2011-11-17 · 15y expired

What this patent protects

The invention relates to an aqueous pharmaceutical composition, preferably an infusion solution, for parenteral administration which contains paracetamol and has an electrical conductivity of not more than 200 μS cm.

USPTO Abstract

The invention relates to an aqueous pharmaceutical composition, preferably an infusion solution, for parenteral administration which contains paracetamol and has an electrical conductivity of not more than 200 μS cm.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010238854A1
Jurisdiction
AU
Classification
—
Expires
2011-11-17
Drug substance claim
No
Drug product claim
No
Assignee
Fresenius Kabi Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.